Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus

Experimental and Therapeutic Medicine

Volumn 1, Issue 1, 2010, Pages 137-145

  Yoshida, Tetsuro ^a   Kato, Kimihiko ^b   Yokoi, Kiyoshi ^b   Oguri, Mitsutoshi ^c   Watanabe, Sachiro ^d   Metoki, Norifumi ^e   Yoshida, Hidemi ^f   Satoh, Kei ^f   Aoyagi, Yukitoshi ^g   Nozawa, Yoshinori ^h   Yamada, Yoshiji ⁱ  

^a Inabe General Hospital   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^e Hirosaki Stroke Center   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^h Tokai Women's Junior College   (Japan)

ⁱ MIE UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Diabetes mellitus; Genetics; Hypertension; Polymorphism

Indexed keywords

CADHERIN; PHOSPHOLIPASE A2 GROUP III; PROTEIN TYROSINE PHOSPHATASE; ZINC FINGER PROTEIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77955728746     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000023     Document Type: Article

References (24)

1. Foley RN, Parfrey PS and Sarnak MJ: Clinical Epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: 112-119, 1998.
2. Go AS, Chertow GM, Fan D, Mcculloch CE and Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 351: 1296-1305, 2004.
3. Ruilope LM, Salvetti A, Jamerson K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (hot) Study. J am Soc nephrol 12: 218-225, 2001.
4. National Kidney Foundation: K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classifcation, and stratifcation. Am J Kidney Dis 39: 1-266, 2002.
5. Gharavi AG, Yan Y, Scolari F, et al: IGa Nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26: 354-357, 2000.
6. Hanson RL, Craig DW and Millis MP: Identifcation of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56: 975-983, 2007.
7. Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S and Tokunaga K: Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol 17: 823-830, 2006.
8. Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O and Johansen KL: interleukin-1 gene cluster polymorphisms predict risk of ESrd. Kidney INT 68: 278-284, 2005.
9. Yoshida T, Kato K, Fujimaki T, et al: Association of a polymorphism of the Apolipoprotein e gene with chronic kidney disease in Japanese individuals with metabolic syndrome. Genomics 93: 221-226, 2009.
10. Yoshida T, Kato K, Yokoi K, et al: Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus. Int J Mol Med 23: 529-537, 2009.
11. Yoshida T, Kato K, Yokoi K, et al: Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension. Hypertens Res 32: 411-418, 2009.
12. Yoshida T, Kato K, Yokoi K, et al: Association of genetic variants with chronic kidney disease in individuals with different lipid profles. Int J Mol Med 24: 233246, 2009.
13. Matsuo S, Imai E, Horio M, et al: Revised equations for estimated Gfr from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.
14. Yamada Y, Fuku N, Tanaka M, et al: Identifcation of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis: e-pub ahead of print, 2009.
15. Yoshida T, Kato K, Fujimaki T, et al: Association of genetic variants with chronic kidney disease in Japanese individuals. Clin J Am Soc Nphrol 4: 883-890, 2009.
16. Yoshida T, Kato K, Yokoi K, et al: Association of gene polymorphisms with chronic kidney disease in high-risk or low-risk subjects defned by conventional risk factors. Int J Mol Med 23: 785-792, 2009.
17. Itoh Y, mizuki N, Shimada T, et al: High-throughput dna typing of hla-a, -b, -c and -drb1 loci by a pcr-SSop-luminex method in the Japanese population. Immunogenetics 57: 717-729, 2005.
18. Suzuki S, Sano K and Tanihara H: Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul 2: 261-270, 1991.
19. Miotto E, Sabbioni S, Veronese A, et al: Frequent aberrant methylation of the cdh4 gene promoter in human colorectal and gastric cancer. Cancer Res 64: 8156-8159, 2004.
20. Obst-pernberg K, Medina L and Redies C: Expression of R-cadherin and N-cadherin by cell groups and fiber tracts in the developing mouse forebrain: relation to the formation of functional circuits. Neuroscience 106: 505-533, 2001.
21. Cavodeassi F, Carreira-barbosa F, Young RM, et al: Early stages of zebrafsh eye formation require the coordinated activity of Wnt11, fz5 and the Wnt/beta-catenin pathway. Neuron 47: 43-56, 2005.
22. Wasmeier C and Hutton JC: Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem 271: 18161-18170, 1996.
23. Kawasaki E, Hutton JC and Eisenbarth GS: molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes. Biochem Biophys Res Commun 227: 440-447, 1996.
24. Orth SR: Smoking and the kidney. J Am Soc Nephrol 13: 1663-1672, 2002.